ATTENTION-DEFICIT HYPERACTIVITY DISORDER”.

N Engl J Med 2005;352:165-73. Copyright © 2005 Massachusetts Medical Society. A mother brings in her eight-year-old son for evaluation after he is suspended from riding the school bus for jumping out of his seat, teasing other children, and not following directions. He spends two to three hours a night with homework that he never successfully completes. His mother wants to know whether he has attention deficit– hyperactivity disorder. How should he be evaluated and treated?

[1]  M. Sanders,et al.  The Effects of the Triple P-Positive Parenting Program on Preschool Children with Co-Occurring Disruptive Behavior and Attentional/Hyperactive Difficulties , 2002, Journal of abnormal child psychology.

[2]  R. Findling,et al.  A prospective study of stimulant response in preschool children: insights from ROC analyses. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  L. E. Arnold,et al.  Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. , 2003, Journal of child and adolescent psychopharmacology.

[4]  M. Rappley,et al.  Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. , 1999, Archives of pediatrics & adolescent medicine.

[5]  Sharad D. Sawant,et al.  Seizures and prolonged QTc with atomoxetine overdose. , 2004, The American journal of psychiatry.

[6]  J. McClellan,et al.  AACAP Official Action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[7]  M. Rappley,et al.  Patterns of Psychotropic Medication Use in Very Young Children with Attention-Deficit Hyperactivity Disorder , 2002, Journal of developmental and behavioral pediatrics : JDBP.

[8]  D. Gozal,et al.  The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder. , 2003, Sleep medicine.

[9]  R. Shalev,et al.  Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? , 1997, The Journal of pediatrics.

[10]  R. King,et al.  Atomoxetine and tics in ADHD. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[11]  G. Weiss,et al.  Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[12]  C. L. Jensen,et al.  A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. , 2001, The Journal of pediatrics.

[13]  Renate Meyer,et al.  Behavioural problems in children who weigh 1000 g or less at birth in four countries , 2001, The Lancet.

[14]  Richard T. Houang,et al.  The use of methylphenidate in Michigan. , 1995, Archives of pediatrics & adolescent medicine.

[15]  Sarah Durston,et al.  A review of the biological bases of ADHD: what have we learned from imaging studies? , 2003, Mental retardation and developmental disabilities research reviews.

[16]  Joseph Biederman,et al.  Attention Deficit Hyperactivity Disorder in Adults , 2000, JAMA.

[17]  J. Biederman,et al.  Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial , 2001, European Neuropsychopharmacology.

[18]  Joseph Biederman,et al.  Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse? , 2003, Pediatrics.

[19]  R. Barkley,et al.  Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. , 1990, Pediatrics.

[20]  J. Sergeant,et al.  Clinical guidelines for hyperkinetic disorder , 1998, European Child & Adolescent Psychiatry.

[21]  A J Allen,et al.  Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[22]  D. Efron,et al.  Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. , 1997, Pediatrics.

[23]  Alan C. Evans,et al.  Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. , 2002, JAMA.

[24]  K. Schuh,et al.  Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. , 2004, Pediatrics.

[25]  J. W. White,et al.  The effect of sugar on behavior or cognition in children. A meta-analysis. , 1995, JAMA.

[26]  A. Sandler.  Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults , 2002 .

[27]  M. Jarvelin,et al.  Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. , 2003, The American journal of psychiatry.

[28]  J. Biederman,et al.  Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. , 2002, The Journal of clinical psychiatry.

[29]  F. Gary,et al.  Social networks, caregiver strain, and utilization of mental health services among elementary school students at high risk for ADHD. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[30]  D. Lane,et al.  Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[31]  J. Swanson,et al.  Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers , 2001, Journal of developmental and behavioral pediatrics : JDBP.

[32]  J. Powell,et al.  Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization. , 2003, Archives of pediatrics & adolescent medicine.

[33]  G. LeFever,et al.  The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. , 1999, American journal of public health.

[34]  J. Nigg,et al.  A Two-Year Longitudinal Study of Neuropsychological and Cognitive Performance in Relation to Behavioral Problems and Competencies in Elementary School Children , 1999, Journal of abnormal child psychology.

[35]  W. Barbaresi,et al.  How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. , 2002, Archives of pediatrics & adolescent medicine.

[36]  J. Buitelaar,et al.  Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[37]  Allan Reiss,et al.  Bupropion hydrochloride in attention deficit disorder with hyperactivity. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[38]  F. Lynch,et al.  Trends in the prescribing of psychotropic medications to preschoolers. , 2000, JAMA.